Artificial intelligence’s fit in drug development, life sciences

According to Bloomberg Intelligence analysis, life sciences is among the most suitable sectors for AI disruption, given the confluence of decades-old paradigms in drug discovery and highly complex, multidimensional datasets characteristic of biology and chemistry.